Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 18, Number 10—October 2012
Research

Dengue Outbreaks in High-Income Area, Kaohsiung City, Taiwan, 2003–2009

Chia-Hsien LinComments to Author , Karin L. Schiøler, Martin R. Jepsen, Chi-Kung Ho, Shu-Hua Li, and Flemming Konradsen
Author affiliations: University of Copenhagen, Copenhagen, Denmark (C.-H. Lin, K.L. Schiøler, M.R. Jepsen, F. Konradsen); National Taiwan University, Taipei, Taiwan (C.-H. Lin); Kaohsiung City Government, Kaohsiung City, Taiwan (C.-K. Ho, S.-H. Li); Kaohsiung Medical University, Kaohsiung City (C.-K. Ho); and National Sun Yat-Sen University, Kaohsiung City (S.-H. Li)

Main Article

Table 3

Age-specific frequencies of reported clinical manifestations and average reported number of manifestations for confirmed dengue cases (N = 2,087) detected through passive or active surveillance, Kaohsiung City, Taiwan, 2003–2009

Variable Age group, y
0–4 5–14 15–24 25–34 35–44 45–54 55–64 65–74 >74
Passive surveillance system

No. cases

 14 92 161 220 226 310 297 172 57

Average no. manifestations

 3.4 5.0 5.7 5.9 5.5 5.1 4.9 4.5 3.6

Manifestation, no.

Fever

 1.0 1.0 1.0 1.0 1.0 1.0 1.0 0.9 0.9

Anorexia

 0.4 0.7 0.6 0.6 0.6 0.6 0.6 0.6 0.6

Headache

 0.1 0.5 0.7 0.6 0.6 0.6 0.5 0.4 0.3

Arthralgia

 0.0 0.2 0.5 0.6 0.6 0.5 0.5 0.5 0.3

Rash

 0.6 0.7 0.6 0.6 0.5 0.4 0.4 0.3 0.3

Myalgia

 0.1 0.3 0.5 0.6 0.6 0.5 0.5 0.4 0.3

Thirst

 0.3 0.3 0.4 0.5 0.5 0.5 0.5 0.4 0.2

Diarrhea

 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3

Nausea

 0.0 0.3 0.4 0.4 0.3 0.3 0.2 0.3 0.2

Pruritus

 0.1 0.3 0.3 0.3 0.3 0.2 0.2 0.1 0.0

Vomiting

 0.4 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2

Retro-orbital pain

 0.0 0.1 0.2 0.2 0.2 0.1 0.1 0.0 0.0

Hemorrhagic manifestations

 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1
Active surveillance system

No. cases

 7 72 55 59 92 113 80 42 18

Average no. manifestations

 2.2 3.5 4.4 4.6 4.6 3.8 3.1 1.9 1.2

Manifestation, no.

Fever

 1.0 0.8 0.9 0.9 0.8 0.8 0.6 0.4 0.4

Anorexia

 0.1 0.3 0.5 0.4 0.5 0.4 0.4 0.3 0.2

Headache

 0.0 0.5 0.5 0.6 0.5 0.4 0.3 0.2 0.3

Arthralgia

 0.0 0.2 0.2 0.4 0.5 0.4 0.3 0.2 0.2

Rash

 0.4 0.5 0.5 0.5 0.4 0.4 0.3 0.1 0.0

Myalgia

 0.0 0.2 0.3 0.5 0.5 0.4 0.3 0.1 0.1

Thirst

 0.1 0.2 0.3 0.4 0.4 0.4 0.3 0.2 0.1

Diarrhea

 0.3 0.2 0.2 0.3 0.3 0.2 0.2 0.1 0.1

Nausea

 0.0 0.1 0.3 0.2 0.2 0.2 0.2 0.1 0.0

Pruritus

 0.1 0.3 0.4 0.3 0.3 0.2 0.2 0.1 0.0

Vomiting

 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0

Retro-orbital pain

 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0

Hemorrhagic manifestations

 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0

Main Article

Page created: September 13, 2012
Page updated: September 13, 2012
Page reviewed: September 13, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external